Pediatrix Medical Group, Inc. $MD Shares Sold by Dana Investment Advisors Inc.

Dana Investment Advisors Inc. lessened its stake in shares of Pediatrix Medical Group, Inc. (NYSE:MD) by 19.1% during the fourth quarter, Holdings Channel.com reports. The institutional investor owned 648,721 shares of the company’s stock after selling 152,741 shares during the period. Dana Investment Advisors Inc.’s holdings in Pediatrix Medical Group were worth $13,876,000 at the end of the most recent reporting period.

A number of other institutional investors and hedge funds also recently added to or reduced their stakes in MD. Allworth Financial LP lifted its holdings in Pediatrix Medical Group by 1,177.5% in the 4th quarter. Allworth Financial LP now owns 10,833 shares of the company’s stock valued at $232,000 after purchasing an additional 9,985 shares in the last quarter. Swiss Life Asset Management Ltd purchased a new position in Pediatrix Medical Group in the 4th quarter valued at about $230,000. Truist Financial Corp purchased a new position in Pediatrix Medical Group in the 4th quarter valued at about $231,000. Seizert Capital Partners LLC lifted its holdings in Pediatrix Medical Group by 41.7% in the 4th quarter. Seizert Capital Partners LLC now owns 16,234 shares of the company’s stock valued at $347,000 after purchasing an additional 4,779 shares in the last quarter. Finally, Jennison Associates LLC purchased a new position in Pediatrix Medical Group in the 4th quarter valued at about $768,000. 97.71% of the stock is currently owned by hedge funds and other institutional investors.

Insider Activity at Pediatrix Medical Group

In other news, Director Shirley A. Weis sold 36,028 shares of Pediatrix Medical Group stock in a transaction on Wednesday, May 13th. The stock was sold at an average price of $23.75, for a total value of $855,665.00. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. 1.80% of the stock is currently owned by corporate insiders.

Wall Street Analyst Weigh In

A number of research analysts have issued reports on the stock. Mizuho set a $24.00 target price on shares of Pediatrix Medical Group in a report on Friday, May 8th. Jefferies Financial Group restated a “buy” rating and issued a $27.00 target price on shares of Pediatrix Medical Group in a report on Monday, April 20th. Weiss Ratings restated a “hold (c+)” rating on shares of Pediatrix Medical Group in a report on Friday, March 27th. Truist Financial lifted their price objective on Pediatrix Medical Group from $21.00 to $23.00 and gave the company a “hold” rating in a research report on Monday, April 13th. Finally, Zacks Research downgraded Pediatrix Medical Group from a “strong-buy” rating to a “hold” rating in a research report on Friday, January 23rd. One analyst has rated the stock with a Buy rating and five have issued a Hold rating to the company’s stock. Based on data from MarketBeat, Pediatrix Medical Group presently has an average rating of “Hold” and a consensus price target of $22.50.

Pediatrix Medical Group Price Performance

Shares of NYSE:MD opened at $22.43 on Friday. The company has a market cap of $1.84 billion, a P/E ratio of 10.89 and a beta of 0.70. The company has a quick ratio of 1.33, a current ratio of 1.33 and a debt-to-equity ratio of 0.45. Pediatrix Medical Group, Inc. has a 52 week low of $11.84 and a 52 week high of $24.99. The business has a fifty day simple moving average of $21.54 and a 200-day simple moving average of $21.56.

Pediatrix Medical Group (NYSE:MD) last announced its quarterly earnings data on Tuesday, May 5th. The company reported $0.44 EPS for the quarter, beating analysts’ consensus estimates of $0.37 by $0.07. The business had revenue of $476.20 million during the quarter, compared to the consensus estimate of $465.83 million. Pediatrix Medical Group had a return on equity of 19.94% and a net margin of 9.02%.The business’s revenue for the quarter was up 3.9% on a year-over-year basis. During the same quarter in the previous year, the business earned $0.33 earnings per share. Equities research analysts forecast that Pediatrix Medical Group, Inc. will post 2.08 EPS for the current year.

About Pediatrix Medical Group

Pediatrix Medical Group, Inc (NYSE:MD) is a national physician-led medical group specializing in high-acuity newborn, maternal-fetal and pediatric subspecialty care. Headquartered in Sunrise, Florida, the company delivers clinical services through hospital-based physician staffing, advanced practitioner support and telemedicine programs. Its core specialties include neonatology, maternal-fetal medicine, pediatric cardiology, pediatric critical care, pediatric emergency medicine and anesthesiology.

Founded in 1979 and formerly known as MEDNAX, the company rebranded as Pediatrix Medical Group in 2022 to align its corporate identity with its primary clinical offerings.